Track topics on Twitter Track topics that are important to you
Pixuvri is a cytotoxic drug designed to inhibit the DNA within cells thereby preventing them from making more DNA copies, which in turn blocks cancer cells from dividing and leads to their death.
The drug currently possesses European regulatory approval as monotherapy to treat adults with relapsed or refractory aggressive non-Hodgkin B-cell lymphoma.
Original Article: Servier gains non-Hodgkin lymphoma drug from CTI BioPharmaNEXT ARTICLE
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...